Report of an Amsterdam Working Group on Barrett Esophagus

Virchows Archiv

Volumn 443, Issue 5, 2003, Pages 602-608

  Offerhaus, G J A ^a,b   Correa, P ^c   Van Eeden, S ^a   Geboes, K ^d   Drillenburg, P ^e   Vieth, M ^f   Van Velthuysen, M L ^g   Watanabe, H ^h   Sipponen, P ⁱ   Ten Kate, F J W ^a   Bosman, F T ^j   Bosma, A ^a   Ristimaki, A ^k   Van Dekken, H ^l   Riddell, R ^m   Tytgat, G N J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b LSUMC ^*  (Netherlands)

^c LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^f OTTO VON GUERICKE UNIVERSITY   (Germany)

^g NETHERLANDS CANCER INSTITUTE   (Netherlands)

^h NIIGATA UNIVERSITY   (Japan)

ⁱ JORVI HOSPITAL   (Finland)

^j UNIVERSITY OF LAUSANNE   (Switzerland)

^k HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^l ERASMUS MEDICAL CENTER   (Netherlands)

^m MOUNT SINAI HOSPITAL   (Canada)

more..

Author keywords

Barrett Esophagus; Gastroesophageal reflux; Peptic ulcer

Indexed keywords

BARRETT ESOPHAGUS; CANCER RISK; CLINICAL EXAMINATION; CONFERENCE PAPER; ESOPHAGOSCOPY; GASTROESOPHAGEAL REFLUX; HUMAN; PATHOPHYSIOLOGY; PRECANCER; PRIORITY JOURNAL;

BARRETT ESOPHAGUS; CARCINOMA IN SITU; DIAGNOSIS, DIFFERENTIAL; HUMANS; INTESTINES; METAPLASIA;

EID: 10744228441     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-003-0906-z     Document Type: Conference Paper

References (38)

1. Barrett NR (1950) Chronic peptic ulcer of the oesophagus and 'oesophagitis'. Br J Surg 38:175-182
2. Bian YS, Osterheld MC, Fontolliet C, Bosman FT, Benhattar J (2002) P16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus. J Pathol 96:1113-1121
3. Coppola D, Falcone R, Livingston S, Karl R, Nicosia S, Cacho CM (1997) Cyclin D1 expression correlates with degrees of dysplasia in Barrett's esophagus. Lab Invest 76:298-302
4. De Hertogh G, Van Eyken P, Ectors N, Tack J, Geboes K (2003) On the existence and location of cardiac mucosa: an autopsy study in embryos, fetuses and infants. Gut 52:791-796
5. Ell C, May A, Gossner L et al. (2000) Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 118:670-677
6. Falk GW (2002) Barrett's esophagus. Gastroenterology 122:1569-1591
7. Faller G (2003) Histopathologische Diagnostik der Barrett-Schleimhaut und ihrer neoplasien. Pathologe 24:9-14
8. Garewal H, Ramsey L, Sharma P, Kraus K, Sampliner R (1999) Biomarker studies in reversed Barrett's esophagus. Am J Gastroenterol 94:2829-2833
9. Geboes K, Van Eyken P (2000) The diagnosis of dysplasia and malignancy in Barrett''s oesophagus. Histopathology 37:99-107
10. Goldblum JR (2003) Barrett's esophagus and Barrett's related dysplasia. Mod Pathol 16:316-324
11. Goldstein NS (2000) Gastric cardia intestinal metaplasia: biopsy follow-up study of 85 patients. Mod Pathol 13:1072-1079
12. Haggitt RC (1992) Adenocarcinoma in Barrett's esophagus: a new epidemic? Hum Pathol 23:475-476
13. Hameeteman W, Tytgat GN, Houthoff HJ, Van Den Tweel JG (1989) Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 96:1249-1256
14. Hamilton SR, Aaltonen LA (2000) Pathology and genetics of tumours of the digestive system. WHO classification of tumours. IARC Press, Lyon
15. Hamilton SR, Smith RRL (1987) The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus. Am J Clin Pathol 87:301-312
16. Hoshihara Y, Kogure T, Fukuchi S, et al. (1986) Endoscopic observation of longitudinal vessels at the lower esophagus and its clinical significance (in Japanese with English abstract). Gastrenterol Endosc 28:941-946
17. Krishnadath KK, Tilanus HW, van Blankenstein M, et al. (1995) Accumulation of genetic abnormalities during neoplastic progression in Barrett's esophagus. Cancer Res 55:1971-1976
18. Lagorce Pages, Paraf F, Dubois S, Belghiti J, Flejou JF (1998) Expression of CD44 in premalignant and malignant Barrett's oesophagus. Histopathology 32:7-14
19. Latchford A, Eksteen B, Jankowski J (2001) The continuing story of cytokeratins in Barrett's mucosa: as you like it. Gut 49:746-749
20. May A, Gossner L, Pech O, et al (2002) Local endoscopic therapy for intraepithelial high grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute phase and intermediate results of a new treatment approach. Eur J Gastroenterol Hep 14:1085-1091
21. Montgomery E, Bronner MP, Goldblum JR, et al. (2001) Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol 32:368-378
22. Nijhawan PK, Wang KK (2000) Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high grade dysplasia with Barrett's esophagus. Gastrointest Endosc 52:328-332
23. Overholt BF, Panjehpour M (1996) Photodynamic therapy for Barrett's esophagus: clinical update. Am J Gastroenterol 91:1719-1723
24. Paull A, Trier JS, Dalton MD, Camp RC, Loeb P, Goyal RK (1976) The histologic spectrum of Barrett's esophagus. N Engl J Med 295:476-480
25. Polkowski W, Baak JPA, van Lanschot JJB, et al. (1998) Clinical decision making in Barrett esophagus can be supported by computerized immunoquantitation and morphometry of features associated with proliferation and differentiation. J Pathol 184:161-168
26. Polkowski W, van Lanscot JJ, ten Kate FJ, et al. (2000) Intestinal and pancreatic metaplasia at the gastroesophageal junction in patients without Barrett's esophagus. Am J Gastroenterol 95:617-625
27. Reid BJ, Weinstein WM, Lewin KJ, Haggitt RC, VanDeventer G, Den Besten L, Rubin CE (1988) Endoscopic biopsies diagnose high grade dysplasia or early operable adencarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology 94:81-90
28. Reid BJ, Blount PL, Rubin CE, Levine DS, Haggitt RC, Rabinovitch PS (1992) Predictors of progression to malignancy in Barrett's esophagus: endoscopic, histologic, and flow-cytometric follow-up of a cohort. Gastroenterology 102:1212-1219
29. Riddell RH, Goldman H, Ransohoff DF, et al. (1983) Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical implications. Hum Pathol 14:931-968
30. Riddell RH (1996) The biopsy diagnosis of gastroesophageal reflux disease, carditis, and Barrett's esophagus, and sequelea of therapy. Am J Surg Pathol 20[Suppl 1]:31-51
31. Sampliner RE (1998) Practice guidelines on the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 93:1028-1031
32. Spechler SJ, Goyal RK (1986) Barrett's esophagus. N Engl J Med 315:362-371
33. Takubo K, Sasajima K, Yamashita K, et al. (1991) Double muscularis mucosae in Barrett's esophagus. Hum Pathol 22:1158-1161
34. Takubo K (2000) Pathology of the Esophagus. Educa Inc, Tokyo
35. Van Laethem JL, Peny MO, Salmon I, Cremer M, Deviere J (2000) Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus. Gut 46:574-577
36. Van Sandick JW, Baak JPA, van Lanscot JJB, et al. (2000) Computerized quantitative pathology for the grading of dysplasia in surveillance biopsies of Barrett oesophagus. J Pathol 190:177-183
37. Van Sandick JW, van Lanschot JJB, van Felius L, et al. (2002) Intestinal metaplasia of the esophagus or esophagogastric junction. Evidence of distinct clinical, pathologic, and histochemical staining features. Am J Clin Pathol 117:117-125
38. Willis J, Riddell RH (2003) Biology versus terminology: east meets west in surgical pathology. Gastrointest Endosc 57:369-376